nodes	percent_of_prediction	percent_of_DWPC	metapath
Tiotropium—CHRM2—forebrain—attention deficit hyperactivity disorder	0.00799	0.0696	CbGeAlD
Tiotropium—CHRM1—forebrain—attention deficit hyperactivity disorder	0.00727	0.0634	CbGeAlD
Tiotropium—CHRM2—cardiovascular system—attention deficit hyperactivity disorder	0.00675	0.0589	CbGeAlD
Tiotropium—CHRM3—forebrain—attention deficit hyperactivity disorder	0.00651	0.0567	CbGeAlD
Tiotropium—CHRM5—nervous system—attention deficit hyperactivity disorder	0.00632	0.0551	CbGeAlD
Tiotropium—CHRM1—cardiovascular system—attention deficit hyperactivity disorder	0.00615	0.0536	CbGeAlD
Tiotropium—CHRM5—central nervous system—attention deficit hyperactivity disorder	0.00608	0.053	CbGeAlD
Tiotropium—CHRM5—brain—attention deficit hyperactivity disorder	0.00483	0.0421	CbGeAlD
Tiotropium—CHRM2—nervous system—attention deficit hyperactivity disorder	0.00434	0.0378	CbGeAlD
Tiotropium—SLC22A4—cerebellum—attention deficit hyperactivity disorder	0.00421	0.0367	CbGeAlD
Tiotropium—CHRM2—central nervous system—attention deficit hyperactivity disorder	0.00418	0.0364	CbGeAlD
Tiotropium—CHRM1—nervous system—attention deficit hyperactivity disorder	0.00395	0.0344	CbGeAlD
Tiotropium—CHRM1—central nervous system—attention deficit hyperactivity disorder	0.0038	0.0331	CbGeAlD
Tiotropium—SLC22A5—midbrain—attention deficit hyperactivity disorder	0.0036	0.0314	CbGeAlD
Tiotropium—CHRM3—nervous system—attention deficit hyperactivity disorder	0.00353	0.0308	CbGeAlD
Tiotropium—CYP2D6—forebrain—attention deficit hyperactivity disorder	0.00352	0.0307	CbGeAlD
Tiotropium—SLC22A4—brain—attention deficit hyperactivity disorder	0.00342	0.0298	CbGeAlD
Tiotropium—CHRM3—central nervous system—attention deficit hyperactivity disorder	0.0034	0.0296	CbGeAlD
Tiotropium—CHRM2—brain—attention deficit hyperactivity disorder	0.00331	0.0289	CbGeAlD
Tiotropium—CHRM1—brain—attention deficit hyperactivity disorder	0.00302	0.0263	CbGeAlD
Tiotropium—SLC22A5—cerebellum—attention deficit hyperactivity disorder	0.00279	0.0243	CbGeAlD
Tiotropium—CHRM3—brain—attention deficit hyperactivity disorder	0.0027	0.0235	CbGeAlD
Tiotropium—SLC22A5—brain—attention deficit hyperactivity disorder	0.00226	0.0197	CbGeAlD
Tiotropium—CYP3A4—nervous system—attention deficit hyperactivity disorder	0.00194	0.0169	CbGeAlD
Tiotropium—CYP2D6—nervous system—attention deficit hyperactivity disorder	0.00191	0.0166	CbGeAlD
Tiotropium—CYP3A4—central nervous system—attention deficit hyperactivity disorder	0.00187	0.0163	CbGeAlD
Tiotropium—CYP2D6—central nervous system—attention deficit hyperactivity disorder	0.00184	0.016	CbGeAlD
Tiotropium—CYP2D6—cerebellum—attention deficit hyperactivity disorder	0.0018	0.0157	CbGeAlD
Tiotropium—CYP2D6—brain—attention deficit hyperactivity disorder	0.00146	0.0127	CbGeAlD
Tiotropium—CHRM1—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.0011	0.00124	CbGpPWpGaD
Tiotropium—CHRM5—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.00109	0.00124	CbGpPWpGaD
Tiotropium—CHRM3—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.00109	0.00123	CbGpPWpGaD
Tiotropium—CHRM1—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.00108	0.00122	CbGpPWpGaD
Tiotropium—CHRM2—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.00108	0.00122	CbGpPWpGaD
Tiotropium—CHRM3—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.00108	0.00122	CbGpPWpGaD
Tiotropium—CHRM2—G alpha (i) signalling events—DRD2—attention deficit hyperactivity disorder	0.00107	0.00121	CbGpPWpGaD
Tiotropium—CHRM5—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.00107	0.00121	CbGpPWpGaD
Tiotropium—CHRM2—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.00107	0.00121	CbGpPWpGaD
Tiotropium—CHRM5—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.00107	0.00121	CbGpPWpGaD
Tiotropium—CHRM1—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.00106	0.0012	CbGpPWpGaD
Tiotropium—CHRM3—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.00106	0.0012	CbGpPWpGaD
Tiotropium—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.00105	0.00118	CbGpPWpGaD
Tiotropium—CHRM2—SIDS Susceptibility Pathways—HTR2A—attention deficit hyperactivity disorder	0.00104	0.00118	CbGpPWpGaD
Tiotropium—CHRM1—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.00104	0.00118	CbGpPWpGaD
Tiotropium—CHRM3—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.00104	0.00117	CbGpPWpGaD
Tiotropium—CHRM5—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.00103	0.00117	CbGpPWpGaD
Tiotropium—CHRM2—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.00103	0.00116	CbGpPWpGaD
Tiotropium—CHRM5—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.00102	0.00115	CbGpPWpGaD
Tiotropium—CHRM1—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.00101	0.00114	CbGpPWpGaD
Tiotropium—CHRM3—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.00101	0.00114	CbGpPWpGaD
Tiotropium—CHRM5—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.001	0.00113	CbGpPWpGaD
Tiotropium—CHRM5—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.001	0.00113	CbGpPWpGaD
Tiotropium—CHRM2—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.000996	0.00113	CbGpPWpGaD
Tiotropium—CHRM5—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.000993	0.00112	CbGpPWpGaD
Tiotropium—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.000987	0.00112	CbGpPWpGaD
Tiotropium—CHRM3—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.000984	0.00111	CbGpPWpGaD
Tiotropium—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.000974	0.0011	CbGpPWpGaD
Tiotropium—CHRM5—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.000973	0.0011	CbGpPWpGaD
Tiotropium—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.000956	0.00108	CbGpPWpGaD
Tiotropium—SLC22A5—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000954	0.00108	CbGpPWpGaD
Tiotropium—CHRM3—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.000953	0.00108	CbGpPWpGaD
Tiotropium—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.000944	0.00107	CbGpPWpGaD
Tiotropium—CHRM1—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.00094	0.00106	CbGpPWpGaD
Tiotropium—CHRM3—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.000937	0.00106	CbGpPWpGaD
Tiotropium—CHRM5—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.000935	0.00106	CbGpPWpGaD
Tiotropium—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.000928	0.00105	CbGpPWpGaD
Tiotropium—CHRM2—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.000928	0.00105	CbGpPWpGaD
Tiotropium—CHRM3—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.000925	0.00105	CbGpPWpGaD
Tiotropium—CHRM1—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.000925	0.00104	CbGpPWpGaD
Tiotropium—CHRM3—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.000922	0.00104	CbGpPWpGaD
Tiotropium—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.000916	0.00103	CbGpPWpGaD
Tiotropium—CHRM1—G alpha (q) signalling events—HTR2A—attention deficit hyperactivity disorder	0.000914	0.00103	CbGpPWpGaD
Tiotropium—CHRM2—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.000913	0.00103	CbGpPWpGaD
Tiotropium—CHRM3—G alpha (q) signalling events—HTR2A—attention deficit hyperactivity disorder	0.000911	0.00103	CbGpPWpGaD
Tiotropium—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.00088	0.000994	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.000874	0.000988	CbGpPWpGaD
Tiotropium—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.000865	0.000977	CbGpPWpGaD
Tiotropium—CHRM3—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.000862	0.000974	CbGpPWpGaD
Tiotropium—CHRM5—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.00086	0.000971	CbGpPWpGaD
Tiotropium—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.000853	0.000964	CbGpPWpGaD
Tiotropium—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—attention deficit hyperactivity disorder	0.000818	0.000924	CbGpPWpGaD
Tiotropium—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—attention deficit hyperactivity disorder	0.000815	0.000921	CbGpPWpGaD
Tiotropium—CHRM1—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.000809	0.000913	CbGpPWpGaD
Tiotropium—CHRM3—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.000806	0.00091	CbGpPWpGaD
Tiotropium—CHRM2—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.000798	0.000902	CbGpPWpGaD
Tiotropium—CHRM1—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.00077	0.00087	CbGpPWpGaD
Tiotropium—CHRM3—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.000767	0.000867	CbGpPWpGaD
Tiotropium—CHRM2—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.00076	0.000858	CbGpPWpGaD
Tiotropium—CHRM1—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.000754	0.000852	CbGpPWpGaD
Tiotropium—CHRM3—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.000752	0.000849	CbGpPWpGaD
Tiotropium—CHRM1—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.000752	0.000849	CbGpPWpGaD
Tiotropium—CHRM3—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.000749	0.000846	CbGpPWpGaD
Tiotropium—CHRM2—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.000744	0.000841	CbGpPWpGaD
Tiotropium—CHRM5—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.000742	0.000839	CbGpPWpGaD
Tiotropium—CHRM2—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.000742	0.000838	CbGpPWpGaD
Tiotropium—CHRM1—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.000728	0.000822	CbGpPWpGaD
Tiotropium—CHRM3—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.000726	0.00082	CbGpPWpGaD
Tiotropium—CYP2D6—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.00072	0.000813	CbGpPWpGaD
Tiotropium—CHRM2—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.000719	0.000812	CbGpPWpGaD
Tiotropium—CHRM1—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.000716	0.000808	CbGpPWpGaD
Tiotropium—CYP2D6—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000715	0.000807	CbGpPWpGaD
Tiotropium—CHRM3—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.000713	0.000806	CbGpPWpGaD
Tiotropium—CYP2D6—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.00071	0.000802	CbGpPWpGaD
Tiotropium—CHRM1—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.000707	0.000798	CbGpPWpGaD
Tiotropium—CHRM1—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.000707	0.000798	CbGpPWpGaD
Tiotropium—CHRM2—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.000706	0.000798	CbGpPWpGaD
Tiotropium—CHRM3—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.000705	0.000796	CbGpPWpGaD
Tiotropium—CHRM3—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.000704	0.000796	CbGpPWpGaD
Tiotropium—CHRM1—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.000699	0.00079	CbGpPWpGaD
Tiotropium—CHRM2—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.000698	0.000788	CbGpPWpGaD
Tiotropium—CHRM2—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.000698	0.000788	CbGpPWpGaD
Tiotropium—CHRM3—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.000697	0.000787	CbGpPWpGaD
Tiotropium—CHRM2—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.00069	0.00078	CbGpPWpGaD
Tiotropium—CHRM1—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.000685	0.000774	CbGpPWpGaD
Tiotropium—CHRM3—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.000683	0.000771	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.000683	0.000771	CbGpPWpGaD
Tiotropium—CHRM2—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.000676	0.000764	CbGpPWpGaD
Tiotropium—CHRM5—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.000674	0.000762	CbGpPWpGaD
Tiotropium—CHRM1—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.000658	0.000744	CbGpPWpGaD
Tiotropium—CHRM3—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.000656	0.000741	CbGpPWpGaD
Tiotropium—CHRM5—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.000655	0.00074	CbGpPWpGaD
Tiotropium—CHRM2—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.00065	0.000734	CbGpPWpGaD
Tiotropium—CHRM5—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.000649	0.000733	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.000616	0.000696	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.000614	0.000693	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.000608	0.000687	CbGpPWpGaD
Tiotropium—CHRM1—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.000606	0.000684	CbGpPWpGaD
Tiotropium—CHRM3—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.000604	0.000682	CbGpPWpGaD
Tiotropium—CHRM5—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.000603	0.000681	CbGpPWpGaD
Tiotropium—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.000598	0.000675	CbGpPWpGaD
Tiotropium—CHRM5—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.000589	0.000666	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000587	0.000663	CbGpPWpGaD
Tiotropium—CHRM5—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.000584	0.00066	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000575	0.000649	CbGpPWpGaD
Tiotropium—CHRM5—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.000574	0.000649	CbGpPWpGaD
Tiotropium—CHRM5—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.000567	0.000641	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000563	0.000637	CbGpPWpGaD
Tiotropium—CHRM2—SIDS Susceptibility Pathways—EP300—attention deficit hyperactivity disorder	0.000553	0.000624	CbGpPWpGaD
Tiotropium—CHRM5—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.000548	0.000619	CbGpPWpGaD
Tiotropium—CHRM5—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000531	0.000599	CbGpPWpGaD
Tiotropium—CHRM5—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.000528	0.000597	CbGpPWpGaD
Tiotropium—CHRM1—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.000523	0.000591	CbGpPWpGaD
Tiotropium—CHRM5—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000522	0.000589	CbGpPWpGaD
Tiotropium—CHRM3—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.000521	0.000589	CbGpPWpGaD
Tiotropium—CHRM2—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.000516	0.000583	CbGpPWpGaD
Tiotropium—CHRM5—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.000515	0.000582	CbGpPWpGaD
Tiotropium—CHRM3—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000492	0.000556	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.000481	0.000543	CbGpPWpGaD
Tiotropium—CHRM5—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.00048	0.000542	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.000479	0.000541	CbGpPWpGaD
Tiotropium—CHRM1—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.000475	0.000536	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.000474	0.000536	CbGpPWpGaD
Tiotropium—CHRM3—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.000473	0.000535	CbGpPWpGaD
Tiotropium—CYP3A4—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000471	0.000532	CbGpPWpGaD
Tiotropium—CHRM2—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.000469	0.000529	CbGpPWpGaD
Tiotropium—CYP3A4—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000467	0.000528	CbGpPWpGaD
Tiotropium—CYP3A4—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000464	0.000524	CbGpPWpGaD
Tiotropium—CHRM1—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.000461	0.000521	CbGpPWpGaD
Tiotropium—CHRM3—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.00046	0.000519	CbGpPWpGaD
Tiotropium—CHRM1—Circadian rythm related genes—EP300—attention deficit hyperactivity disorder	0.000457	0.000516	CbGpPWpGaD
Tiotropium—CHRM1—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.000457	0.000516	CbGpPWpGaD
Tiotropium—CHRM3—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.000455	0.000515	CbGpPWpGaD
Tiotropium—CHRM2—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.000455	0.000514	CbGpPWpGaD
Tiotropium—CHRM2—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.000451	0.00051	CbGpPWpGaD
Tiotropium—CHRM1—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.000425	0.00048	CbGpPWpGaD
Tiotropium—CHRM3—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.000423	0.000478	CbGpPWpGaD
Tiotropium—CHRM2—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.000419	0.000474	CbGpPWpGaD
Tiotropium—CHRM1—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.000415	0.000469	CbGpPWpGaD
Tiotropium—CHRM3—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.000414	0.000467	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000413	0.000466	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000412	0.000465	CbGpPWpGaD
Tiotropium—CHRM1—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.000411	0.000465	CbGpPWpGaD
Tiotropium—CHRM3—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.00041	0.000463	CbGpPWpGaD
Tiotropium—CHRM2—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.00041	0.000463	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000408	0.00046	CbGpPWpGaD
Tiotropium—CHRM2—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.000406	0.000459	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000405	0.000457	CbGpPWpGaD
Tiotropium—CHRM1—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.000404	0.000457	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000403	0.000456	CbGpPWpGaD
Tiotropium—CHRM3—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.000403	0.000455	CbGpPWpGaD
Tiotropium—CHRM1—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.000399	0.000451	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000399	0.000451	CbGpPWpGaD
Tiotropium—CHRM2—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.000399	0.000451	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000398	0.00045	CbGpPWpGaD
Tiotropium—CHRM3—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.000398	0.00045	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000397	0.000448	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000395	0.000447	CbGpPWpGaD
Tiotropium—CHRM2—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.000394	0.000445	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000392	0.000442	CbGpPWpGaD
Tiotropium—CHRM1—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.000386	0.000436	CbGpPWpGaD
Tiotropium—CHRM3—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.000385	0.000434	CbGpPWpGaD
Tiotropium—CHRM2—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.000381	0.00043	CbGpPWpGaD
Tiotropium—CHRM1—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000374	0.000422	CbGpPWpGaD
Tiotropium—CHRM3—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000372	0.000421	CbGpPWpGaD
Tiotropium—CHRM1—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.000372	0.00042	CbGpPWpGaD
Tiotropium—CHRM3—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.000371	0.000419	CbGpPWpGaD
Tiotropium—CHRM5—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.00037	0.000418	CbGpPWpGaD
Tiotropium—CHRM2—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000369	0.000417	CbGpPWpGaD
Tiotropium—CHRM2—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.000367	0.000415	CbGpPWpGaD
Tiotropium—CHRM1—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000367	0.000415	CbGpPWpGaD
Tiotropium—CHRM3—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000366	0.000413	CbGpPWpGaD
Tiotropium—CHRM1—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.000363	0.00041	CbGpPWpGaD
Tiotropium—CHRM2—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000362	0.000409	CbGpPWpGaD
Tiotropium—CHRM3—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.000362	0.000408	CbGpPWpGaD
Tiotropium—CHRM2—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.000358	0.000404	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000348	0.000393	CbGpPWpGaD
Tiotropium—CHRM3—Metabolism—TPH2—attention deficit hyperactivity disorder	0.00034	0.000384	CbGpPWpGaD
Tiotropium—CHRM3—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.00034	0.000384	CbGpPWpGaD
Tiotropium—CHRM1—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000338	0.000382	CbGpPWpGaD
Tiotropium—CHRM3—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000337	0.00038	CbGpPWpGaD
Tiotropium—CHRM5—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000336	0.00038	CbGpPWpGaD
Tiotropium—CHRM3—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000334	0.000378	CbGpPWpGaD
Tiotropium—CHRM2—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000334	0.000377	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000324	0.000366	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000313	0.000354	CbGpPWpGaD
Tiotropium—CHRM3—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000311	0.000351	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000308	0.000348	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000304	0.000344	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000294	0.000333	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000283	0.00032	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.00028	0.000317	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.00028	0.000316	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000277	0.000313	CbGpPWpGaD
Tiotropium—CHRM3—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000272	0.000307	CbGpPWpGaD
Tiotropium—CHRM1—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000261	0.000294	CbGpPWpGaD
Tiotropium—CHRM3—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.00026	0.000293	CbGpPWpGaD
Tiotropium—CHRM3—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000259	0.000292	CbGpPWpGaD
Tiotropium—CHRM2—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000257	0.000291	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000245	0.000277	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000244	0.000276	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000242	0.000273	CbGpPWpGaD
Tiotropium—CHRM1—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000237	0.000267	CbGpPWpGaD
Tiotropium—CHRM3—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000236	0.000266	CbGpPWpGaD
Tiotropium—CHRM2—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000234	0.000264	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000228	0.000257	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000227	0.000257	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000225	0.000254	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000221	0.000249	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.00022	0.000249	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000218	0.000246	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000217	0.000245	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000216	0.000244	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000214	0.000242	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000214	0.000242	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000214	0.000241	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000211	0.000239	CbGpPWpGaD
Tiotropium—CHRM3—Metabolism—COMT—attention deficit hyperactivity disorder	0.000206	0.000233	CbGpPWpGaD
Tiotropium—CHRM3—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000204	0.000231	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000203	0.00023	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000203	0.00023	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—DPYD—attention deficit hyperactivity disorder	0.0002	0.000226	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.0002	0.000225	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000199	0.000225	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000199	0.000224	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000197	0.000223	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000192	0.000217	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000186	0.00021	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000162	0.000183	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000155	0.000175	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.00014	0.000158	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000139	0.000157	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000138	0.000156	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000133	0.00015	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000133	0.00015	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000131	0.000148	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—COMT—attention deficit hyperactivity disorder	0.000123	0.000139	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000122	0.000138	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000121	0.000137	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000106	0.00012	CbGpPWpGaD
Tiotropium—CHRM5—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.000105	0.000119	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000101	0.000114	CbGpPWpGaD
Tiotropium—CHRM3—Metabolism—EP300—attention deficit hyperactivity disorder	8.83e-05	9.97e-05	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—COMT—attention deficit hyperactivity disorder	8.05e-05	9.09e-05	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—MAOA—attention deficit hyperactivity disorder	7.99e-05	9.03e-05	CbGpPWpGaD
Tiotropium—CHRM1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	7.41e-05	8.37e-05	CbGpPWpGaD
Tiotropium—CHRM3—Signaling Pathways—EP300—attention deficit hyperactivity disorder	7.38e-05	8.34e-05	CbGpPWpGaD
Tiotropium—CHRM2—Signaling Pathways—EP300—attention deficit hyperactivity disorder	7.31e-05	8.26e-05	CbGpPWpGaD
Tiotropium—CYP2D6—Metabolism—EP300—attention deficit hyperactivity disorder	5.28e-05	5.96e-05	CbGpPWpGaD
Tiotropium—CYP3A4—Metabolism—EP300—attention deficit hyperactivity disorder	3.45e-05	3.9e-05	CbGpPWpGaD
